KENDRA FOREMAN: Open Payments
NPI 1366924763 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,318 in 162 payments from 28 companies in 2025. Trend: 2023 $3,887 · 2024 $3,576 · 2025 $3,318
Food & beverage: $3,318
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $406 |
| UCB, Inc. | 19 | $380 |
| Biogen, Inc. | 14 | $322 |
| Neurocrine BioSciences, Inc. | 18 | $295 |
| Eisai Inc. | 11 | $278 |
| Novartis Pharmaceuticals Corporation | 11 | $194 |
| ANI Pharmaceuticals, Inc. | 5 | $177 |
| Mallinckrodt Hospital Products Inc. | 3 | $159 |
| ACADIA Pharmaceuticals Inc | 8 | $158 |
| TG Therapeutics, Inc. | 1 | $124 |
Products named: Zilbrysq, INGREZZA, Leqembi, QULIPTA, PURIFIED CORTROPHIN GEL, KESIMPTA, VUMERITY, ACTHAR.
Industry payments across AZ — which companies pay providers there.
